The abnormal gene in X-linked lymphoproliferative syndrome

Current Opinion in Immunology

Volumn 11, Issue 4, 1999, Pages 431-434

  Sullivan, John L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APLASTIC ANEMIA; EPSTEIN BARR VIRUS; HODGKIN DISEASE; IMMUNE DEFICIENCY; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR CLONING; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; X CHROMOSOME LINKAGE;

EID: 0033179457     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80072-7     Document Type: Article

References (16)

1. Purtilo DT, Cassel CK, Yank JPS, Harper R: X-linked recessive progressive combined variable immunodificiency (Duncan's disease). Lancet 1975, 7913:935-940.
2. Hamilton JK, Paquin LA, Sullivan JL, Maurer HS, Cruzi FG, Provisor AJ, Steuber CP, Hawkins E, Yawn D, Cornet J et al.: X-linked lymphoproliferative syndrome registry report. J Pediatr 1980, 96:669-673.
3. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, Okano M, Lanyi A, Sumegi J: X-linked lymphoproliferative disease: Twenty-five years after the discovery. Pediatr Res 1995, 38:471-478.
4. Purtilo DT, DeFlorio D, Hutt L, Bhawan J, Yang JPS, Otto R, Edwards W: Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N Engl J Med 1977, 297:1077-1081.
5. Sullivan JL, Byron KS, Brewster FE, Baker S, Ochs H: X-linked lymphoproliferative syndrome. J Clin Invest 1983, 71:1765-1778.
6. Weisenburger DD, Purtilo DT: Failure in immunological control of the virus infection: Fatal infectious mononucleosis. In Epstein-Barr Virus: Recent Advances. Edited by Epstein MA, Achong BG. New York: John Wiley and Sons; 1986:129-158.
7. Sullivan JL, Woda B: X-linked lymphoproliferative syndrome. Immunodefic Rev 1989, 1:324-347.
8. Schuster V, Kreth HW: X-linked lymphoproliferative disease. In Primary Immunodeficiency Diseases. Edited by Ochs HD, Smith CIE, Puck JM. Oxford: Oxford University Press; 1999:222-232. The most recent, complete review of XLP syndrome.
9. Coffey AJ, Brooksbank RA, Brandau O, Oohaski T, Howell G, Bye JM, Cahn AP, Durham J, Heath P, Wray P et al.: Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998, 20:129-135. This paper, together with [10••, 11••] describes the discovery of the XLP gene, SH2D1A.
10. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG et al.: The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998, 395:462-469. See annotation [9 ••].
11. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E et al.: Inactivating mutations in an SH2 domain-encoding gene in X-lined lumphoproliferative syndrome. Proc Natl Acad Sci USA 1998, 95:13765-13770. See annotation [9 ••].
12. Callan MFC, Tan L, Annels N, Ogg GS, Wilson JDK, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB: Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998, 187:1395-1402.
13. Harada S, Sakamoto J, Seeley JK: Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK) cell activity in the X-linked lymphoproliferative syndrome. Int J Cancer 1982, 30:739-744.
14. Rousett F, Souillet G, Roncarlo MG: Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: Normal EBV-specific HLA-restricted cytotoxicity. Clin Exp Immunol 1986, 63:280-289.
15. Skare JC, Milunsky A, Byron KS, Sullivan JL: Mapping the X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1987, 84:2015-2018.
16. Wyandt H, Grierson H, Sanger W, Skare J, Milunsky A, Purtilo DT: Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease. Am J Med Genet 1989, 33:426-430.